NovartisNovartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group's continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 102,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit

Novartis RSS Channel

Title Filter      Display #  
# Article Title
1 Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
2 Novartis provides drug candidate compounds to TB Alliance
3 Novartis maintained strong innovation momentum in second quarter
4 Novartis to license Google "smart lens" technology
5 Novartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)
6 Novartis launches 7-Day Challenge to 'Live Like You' enabling people with MS to better understand their lives with MS
7 More than 19,000 Novartis associates worldwide volunteer for local causes on Community Partnership Day
8 Novartis delivered solid sales and profit growth in the first quarter of 2014
9 Novartis announces portfolio transformation
10 Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia
11 Novartis announces US FDA approval of Xolair® for chronic idiopathic urticaria
12 Novartis extends leadership in clinical trial data transparency
13 Novartis expands cancer immunotherapy research program with acquisition of CoStim
14 Novartis recognized among world's most sustainable companies in Corporate Knights Global 100
15 Novartis Africa Day highlights company's efforts to expand access to healthcare
16 Novartis Foundation launches new leprosy strategy at symposium on disease elimination
17 Novartis highlights growth prospects driven by significant R&D pipeline progress and the expected increase in blockbuster treatments
18 Novartis announces positive clinical trial results for novel H7N9 vaccine
19 Novartis delivers strong sales performance in third quarter
20 Novartis launches fully interactive Facebook ‘Retina App’ on World Sight Day to raise awareness of retinal disease
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]